Latest news
INTERPACE BIOSCIENCES 2Q 2026: Revenue $9.13M, Net income $158K — 10-Q Summary - TradingViewTradingView · Mon, 10 Aug 2026 21:11:01 GMTInterpace Biosciences (IDXG) stays profitable as revenue falls 12% and preferred converts - Stock TitanStock Titan · Mon, 10 Aug 2026 21:01:21 GMTInterpace Biosciences Announces Second Quarter 2026 Financial and Business Results - The Manila TimesThe Manila Times · Mon, 10 Aug 2026 20:50:54 GMTInterpace Reports $0.3M Q2 Income From Continuing Ops - Stock TitanStock Titan · Mon, 10 Aug 2026 20:35:00 GMTInterpace Diagnostics Group Stock Price Forecast. Should You Buy IDXG? - StockInvest.usStockInvest.us · Fri, 31 Jul 2026 22:33:38 GMT